AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Indivior Pharmaceuticals, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01ZTXFLX8
34.47▼ 0.86 (-2.43%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
35.33
Day's Range
34.10 – 35.35
52-Week Range
24.28 – 42.81
Volume
1.5M
Avg Volume
2.0M
Share Statistics
Shares Outstanding
Employees
838
Exchange
XNAS
Listed
2014-12-24
Share count as of July 28, 2026

Indivior Pharmaceuticals, Inc. Common Stock (INDV) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Indivior Pharmaceuticals, Inc. Common Stock (INDV)
What is Indivior Pharmaceuticals, Inc. Common Stock's Market Cap?
Indivior Pharmaceuticals, Inc. Common Stock's Market Cap is $4.1B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value?
Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value is $4.3B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E?
Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E is 11.4×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales?
Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue?
Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA?
Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 10.1×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?
Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?
Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is $356.0M, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EBITDA?
Indivior Pharmaceuticals, Inc. Common Stock's EBITDA is $430.0M, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?
Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is 3.02, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · INDVAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Net revenue
YoY growth+13.6%+19.2%+19.7%+2.3%
Cost of sales
Gross profit
% of revenue85.7%87.4%81.6%73.2%
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses—
% of revenue39.1%43.8%—59.6%
Operating income
% of revenue46.6%43.2%22.6%13.7%
Other (income) and expenses:
Interest (income)
Interest expense
Loss on debt extinguishment——
Income before income taxes
Income tax expense
Net income
% of revenue35.6%28.1%28.5%13.4%
Basic (in dollars per share)
Diluted (in dollars per share)